Results 121 to 130 of about 26,044 (185)

[Research progress on the mechanisms and optimization strategies of mesenchymal stem cell-derived exosomes in the treatment of liver diseases]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Li XR, Niu B, Zhang LY.
europepmc   +1 more source

肝細胞癌患者においてCTアンギオグラフィーで描出される微小結節の転帰 [PDF]

, 2010
Ohnishi, Hideki
core  

[Inherited metabolic liver disease causing copper deposition]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Jiang H, Liang C, Liu H, Zheng SJ.
europepmc   +1 more source

[Research advances in autoimmune liver disease in 2025: toward precision regulation and personalized treatment]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Shang YL, Han Y.
europepmc   +1 more source

[Research progress and future prospects for artificial intelligence in the diagnosis and treatment of fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Lin YY, Liu F, Rao HY.
europepmc   +1 more source

[Role of Kupffer cells in liver regeneration with metabolic associated fatty liver disease in mice]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang TW, Liu L, Wang SY, Cheng LL, Wang X, Cao YN, Wang YF, Yang LM.   +7 more
europepmc   +1 more source

[Research progress on the multidimensional regulation of gut microbiota on metabolism, immunity, and inflammatory response in metabolic associated fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wu ST, Lu XL.
europepmc   +1 more source

[Exposures to volatile organic compounds are positively correlated with risks of metabolic dysfunction-associated steatotic liver disease]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li K, Zeng W, Zhang Y, Zhu X, Guo B.
europepmc   +1 more source

Diagnostic Pathology [PDF]

, 2011
八田 秀樹, 常山 幸一, 林 伸一, 西田 健志, 野本 一博, 高橋 博之, 髙野 康雄   +6 more
core   +2 more sources

[Research progress on autoimmune liver disease in 2024]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zheng LH, Han Y.
europepmc   +1 more source